Pfizer and BioNTech announced Wednesday that their jointly-developed Covid-19 vaccine is 100% effective at preventing illness in teenagers aged 12 to 15, a major step towards expanding vaccine access as schools begin to return with most products on the market only being licensed for use in late teens and adults.

Stay Connected
Forbes on Facebook:
Forbes Video on Twitter:
Forbes Video on Instagram:
More From Forbes:

Pfizer Says Its Covid 19 Vaccine Is 100% Effective In Young Teens | Forbes